Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Acrivon Therapeutics, Inc. shareholders

As of Sep 30, 2026, 45 institutions reported holding Acrivon Therapeutics, Inc., 49.4% of its shares. Largest: Ra Capital Management, L.P., Sands Capital Alternatives, LLC and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Acrivon Therapeutics, Inc.ChangeFiled
Ra Capital Management, L.P.12.2M28.5%no changeNov 16, 2026
Sands Capital Alternatives, LLC2.29M5.3%no changeNov 13, 2026
Acadian Asset Management LLC1.32M3.1%+153KNov 9, 2026
Vanguard1.3M3.0%+161KNov 13, 2026
Wellington888K2.1%no changeNov 16, 2026
Two Sigma565K1.3%−76,542Nov 16, 2026
Marshall Wace, LLP542K1.3%+10,488Nov 13, 2026
Bridgeway Capital Management, LLC378K0.88%−964Nov 16, 2026
Geode Capital297K0.69%+31,520Nov 6, 2026
BlackRock227K0.53%−12,085Nov 13, 2026

Acrivon Therapeutics, Inc. insider trades